PURPOSE OF REVIEW: Complete parenteral nutrition solutions contain mixed amino acid products providing all nine essential amino acids and a varying composition of nonessential amino acids. Relatively little rigorous comparative efficacy research on altered parenteral nutrition amino acid composition has been published in recent years. RECENT FINDINGS: Limited data from randomized, double-blind, adequately powered clinical trials to define optimal doses of total or individual amino acids in parenteral nutrition are available. An exception is the growing number of studies on the efficacy of glutamine supplementation of parenteral nutrition or given as a single parenteral agent. Parenteral glutamine appears to confer benefit in selected patients; however, additional data to define optimal glutamine dosing and the patient subgroups who may most benefit from this amino acid are needed. Although some promising studies have been published, little data are available in the current era of nutrition support on the clinical efficacy of altered doses of arginine, branched chain amino acids, cysteine, or taurine supplementation of parenteral nutrition. SUMMARY: Despite routine use of parenteral nutrition, surprisingly little clinical efficacy data are available to guide total or specific amino acid dosing in adult and pediatric patients requiring this therapy. This warrants increased attention by the research community and funding agencies to better define optimal amino acid administration strategies in patient subgroups requiring parenteral nutrition.
PURPOSE OF REVIEW: Complete parenteral nutrition solutions contain mixed amino acid products providing all nine essential amino acids and a varying composition of nonessential amino acids. Relatively little rigorous comparative efficacy research on altered parenteral nutrition amino acid composition has been published in recent years. RECENT FINDINGS: Limited data from randomized, double-blind, adequately powered clinical trials to define optimal doses of total or individual amino acids in parenteral nutrition are available. An exception is the growing number of studies on the efficacy of glutamine supplementation of parenteral nutrition or given as a single parenteral agent. Parenteral glutamine appears to confer benefit in selected patients; however, additional data to define optimal glutamine dosing and the patient subgroups who may most benefit from this amino acid are needed. Although some promising studies have been published, little data are available in the current era of nutrition support on the clinical efficacy of altered doses of arginine, branched chain amino acids, cysteine, or taurine supplementation of parenteral nutrition. SUMMARY: Despite routine use of parenteral nutrition, surprisingly little clinical efficacy data are available to guide total or specific amino acid dosing in adult and pediatric patients requiring this therapy. This warrants increased attention by the research community and funding agencies to better define optimal amino acid administration strategies in patient subgroups requiring parenteral nutrition.
Authors: Stephen A McClave; Robert G Martindale; Vincent W Vanek; Mary McCarthy; Pamela Roberts; Beth Taylor; Juan B Ochoa; Lena Napolitano; Gail Cresci Journal: JPEN J Parenter Enteral Nutr Date: 2009 May-Jun Impact factor: 4.016
Authors: C Sornsuvit; S Komindr; S Chuncharunee; P Wanikiat; N Archararit; P Santanirand Journal: J Int Med Res Date: 2008 Nov-Dec Impact factor: 1.671
Authors: Guoyao Wu; Fuller W Bazer; Teresa A Davis; Sung Woo Kim; Peng Li; J Marc Rhoads; M Carey Satterfield; Stephen B Smith; Thomas E Spencer; Yulong Yin Journal: Amino Acids Date: 2008-11-23 Impact factor: 3.520
Authors: Agneta Berg; Bo Michael Bellander; Michael Wanecek; Ake Norberg; Urban Ungerstedt; Olav Rooyackers; Jan Wernerman Journal: Clin Nutr Date: 2008-07-22 Impact factor: 7.324
Authors: Thomas R Ziegler; Addison K May; Gautam Hebbar; Kirk A Easley; Daniel P Griffith; Nisha Dave; Bryan R Collier; George A Cotsonis; Li Hao; Traci Leong; Amita K Manatunga; Eli S Rosenberg; Dean P Jones; Gregory S Martin; Gordon L Jensen; Harry C Sax; Kenneth A Kudsk; John R Galloway; Henry M Blumberg; Mary E Evans; Paul E Wischmeyer Journal: Ann Surg Date: 2016-04 Impact factor: 12.969
Authors: Hubertine M E Willems; Jeremy S Stultz; Molly E Coltrane; Jabez P Fortwendel; Brian M Peters Journal: Antimicrob Agents Chemother Date: 2019-10-22 Impact factor: 5.191
Authors: Thilini N Jayasinghe; Tommi Vatanen; Valentina Chiavaroli; Sachin Jayan; Elizabeth J McKenzie; Evelien Adriaenssens; José G B Derraik; Cameron Ekblad; William Schierding; Malcolm R Battin; Eric B Thorstensen; David Cameron-Smith; Elizabeth Forbes-Blom; Paul L Hofman; Nicole C Roy; Gerald W Tannock; Mark H Vickers; Wayne S Cutfield; Justin M O'Sullivan Journal: Front Cell Infect Microbiol Date: 2020-06-16 Impact factor: 5.293